Zydus Cadila to market anti-psychotic drug
The drug is used to treat schizophrenia and the manic symptoms of bipolar disorder, has received US FDA approval
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Cadila
Zydus Cadila receives US FDA approval for blood pressure drug
The drug will be manufactured at the groups formulations manufacturing facility at pharma SEZ in Ahmedabad
Zydus receives US FDA approval for Temozolomide capsules and Nadolol tablets
Both drugs to be manufactured at the company’s formulations manufacturing facility at the Pharma SEZ, Ahmedabad
Zydus starts phase II trial of ZYAN1 for treating anaemia in patients with CKD
ZYAN1 has been shown to improve iron mobilisation and has the potential to reduce or eliminate the need for iron supplementation
Zydus Cadila gets US FDA nod to market anti-obesity drug
The drug will be produced at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Zydus Cadila to market oxybutynin chloride tablets
Oxybutynin is used to treat overactive bladder and urinary incontinence
Zydus receives US FDA approval for Glyburide and Metformin Hcl tabs
The formulations manufacturing facility at Baddi will produce the drug for the US market
Mankind Pharma launches anti-diabetic product Dynaglipt
Zydus Cadila also launches its generic Tenglyn tablets, Gliptins, in the Indian market for Rs 7 per tablet
Mankind Pharma has…
Zydus launches Adalimuma
Zydus Cadila announced the launch of its biosimilar Adalimumab, following an approval from the Drug Controller General (India)
Zydus launches world’s first biosimilar of Adalimumab
Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile…